Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation

Graham McIlroy, Emmanouil Nikolousis, Nervana Abou-Zeid, Paneesha Shankara, Bhuvan Kishore, Maria Kaparou, Richard Lovell, Shereef Elmoamly, David Davies, Claire Horgan, Amir Shenouda, Alexandros Kanellopoulos*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)202-205
Number of pages4
JournalLeukemia and Lymphoma
Issue number1
Publication statusPublished - 2 Jan 2020

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this